The Food and Drug Administration commissioner reveals what health officials are prioritizing in a forthcoming report on childhood chronic disease.

As Epstein controversy swirls, President Trump signs an executive order aiming to give cities and states more authority to ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...

At a recent U.S. Food and Drug Administration (F.D.A.) panel, doctors argued for the removal of the black box warning on ...

U.S. Food and Drug Administration Commissioner Marty Makary said he is focused on overhauling long-held standards and ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...